heat-tolerant COVID-19 vaccine (Indian Institute of Science/Mynvax)

N/A

Report date: 2025/01/26 19:20:19

Base Information

Drug Nameheat-tolerant COVID-19 vaccine (Indian Institute of Science/Mynvax)
Drug Alias Nameprotein subunit vaccine targeting SARS-CoV-2 spike protein RBD (Indian Institute of Science/Mynvax)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndian Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesIndian Institute Of Science
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A